FLNA:BMV
Filana Therapeutics Inc
15,92 MXN
0,00%
(0,00) 1 д.
5.10, 12:05:31 ч. Гринуич-6 · MXN
search
Всички символи
| Символ | Цена | Промяна | % промяна |
|---|
insights_autoГенерира се водещата статистика за FLNA…
Пазарна кап.
34,14 млн.
Ср. обем
0,00
Обем
0,00
Най-висока цена за 52 седм.
56,00 MXN
Най-ниска цена за 52 седм.
15,92 MXN
Брой служители
19
Пазарна кап.
34,14 млн.
Ср. обем
0,00
Обем
0,00
Най-висока цена за 52 седм.
56,00 MXN
Най-ниска цена за 52 седм.
15,92 MXN
Брой служители
19
Новинарски материали
От източници в мрежата и новинарски партньори
Investor.bg
·
преди 1 ден
Dow Jones добави над 550 пункта, след като инвеститорите се пренасочиха от технологичните акции
Investor.bg
·
преди 1 ден
S&P 500 и Nasdaq Composite спадат, технологичните акции поевтиняват за втори пореден ден
GlobeNewswire
·
преди 10 минути
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Business Wire
·
преди 40 минути
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Профил
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Всичко за Filana Therapeutics Inc
Главен изпълнителен директор-
Служители19
Дата на основаване1998
Централен офисОстин, Тексас, Съединени щати
Бранш-
Уебсайтpaintrials.com